Elite Clinic offers a DNA test prior to pregnancy which prevents genetic disorders in the baby.
The Carrier Screening Test or Carrier Genetic Test (CGT) is an important genetic test when planning a family, because it helps to determine the risk of having a child with a genetic disease. This test tells us whether the parents carry one or more known recessive genetic mutations. Carriers are usually healthy but when two parents carry a mutation in the same gene they might produce an affected child. Anyone, without knowing, can be a carrier of one or more mutations. The Carrier Screening Test allows us to know which genes are altered in each person.
The procedure is carried out through a simple blood analysis.
Link >> The list of genetic diseases tested
Why do a Carrier Screening Test?
Generally, parents only realize they are carriers of serious genetic disorders after an affected child is born. Genetic disorders can’t be cured, but they can be prevented. It is the only clinically validated test.
Who is the Carrier Screening Test for?
We all have changes in our genes and the carrier screening test allows us to find out whether they could cause a disease in our children.
The test is recommended in the following cases:
- Before attempting a pregnancy by natural means:
for any woman who wants to become pregnant in order to know the risk of transmitting possible disorders to her children.
- Before an assisted reproduction treatment:
it is advisable to find out the risk of transmission and to be able to determine the best type of treatment in each case.
- Before treatment with donor sperm or eggs:
In order to be able to select a donor that doesn’t carry the same mutation as the member of the couple who will provide the gametes (eggs or sperm).
Cost of test including CGT match (written information regarding risks and matching):
Analyzes by massive sequencing 6,600 pathogenic mutations and 549 genes linked to more than 600 genetic disorders. It is the most complete panel currently available.
1150 EUR (donor) + 1150 EUR (partner using donor) = 2300 EUR
1150 EUR (female partner) + 1150 EUR (male partner) = 2300 EUR
Panel which includes analysis by massive sequencing (NGS) of 250 genes and 3,500 mutations associated to the most prevalent diseases.
910 EUR (donor) + 910 EUR (partner using the donor) = 1820 EUR
910 EUR (female partner) + 910 EUR (male partner) = 1820 EUR